Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Waters Corporation    WAT

News SummaryMost relevantAll newsSector newsTweets

WATERS CRP : Waters Introduces Highest Performing UPLC Ever Engineered – the new ACQUITY UPLC I-Class

share with twitter share with LinkedIn share with facebook
share via e-mail
06/02/2011 | 12:30pm CEST
Waters Introduces Highest Performing UPLC Ever Engineered – the new ACQUITY UPLC I-Class
The New ACQUITY UPLC I-Class System Takes Separations Technology to the Next Level by Maximizing Peak Capacity and Extending the Performance of any MS Detector
Milford, Mass. - 2011-06-01

Waters Corporation (WAT:NYSE) today introduced the new Waters® ACQUITY UPLC® I-Class System, the highest performing UPLC® system ever engineered taking UltraPerformance LC® separations technology to the next level.  For scientists challenged by the most difficult separations, the ACQUITY UPLC I-Class features the lowest system dispersion and lowest carryover in the industry today. Low dispersion maximizes peak capacity thereby advancing chromatographic separations and optimizing the performance of any mass spectrometer.

“The scientific discoveries with the biggest potential to improve our lives often rely on samples and compounds that are the most difficult to understand. The ACQUITY UPLC I-Class System was designed specifically for the rapid pace of laboratories on the cutting edge of research,” said Art Caputo, President of the Waters Division. “Design and function of the I-Class are based on continuous customer input resulting in improvements in sub-two-micron separation that only the originator of the technology can exploit. Whether customers need to rapidly analyze sample-limited compounds amid a complex matrix or they seek to optimize the performance of any mass spectrometer on the market, ACQUITY UPLC I-Class enables scientists to solve their most complex separations and detection challenges.”

Keeping pace with today’s most advanced laboratories, the ACQUITY UPLC I-Class System excels when analyzing complex, sample-limited compounds.   Sample-limited compounds include high potency medications, trace levels of food or water contamination, and (advanced) sophisticated biotherapeutics.  These samples can represent complex separation challenges requiring an LC system that can maximize the benefits of sub-two-micron for faster throughput and optimized MS performance.

While there are many innovations built into the new ACQUITY UPLC I-Class, minimal system volume is a new key feature. Reduced system volume significantly decreases dispersion rates for reproducibly higher resolution and superior peak capacity. Reduced dispersion and small peak volumes extend the sensitivity of any mass spectrometer. Additionally, low dispersion footprint allows users to reduce their separation cycle times without impact to the separation as resolution is maintained even for ballistic gradients lasting less than one minute. Also importantly, new   design and materials dramatically reduce sample carryover effects, thus increasing user confidence in results.

The ACQUITY UPLC I-Class also features class leading flexibility and precise sampling capabilities. Depending on application needs, users can choose either the highest precision and lowest dispersion fixed-loop Sample Manager, or the world’s first low dispersion variable volume Sample Manager with a flow-through needle design, which delivers high-precision injections, excellent sample recovery, and lowest sample carryover optimizing the performance for even the most sensitive mass detectors.


Seven years ago, Waters pioneered a new category of chromatographic performance with the commercialization of sub-2-

share with twitter share with LinkedIn share with facebook
share via e-mail
10/02 WATERS CORPORATION : Q3 2017 Financial Results Webcast Invitation
09/07 WATERS : Researchers from Waters Corporation Report Recent Findings in Chromatog..
09/05 WATERS CORPORATION : Commentary at the Morgan Stanley Global Healthcare Conferen..
08/31 WATERS : Medical Supplies Stock Performance Review -- Integra LifeSciences, Anta..
08/09 INSIDER TRADING ACTIVITY WATERS CORP : WAT) – Director Sold 3,500 shares o..
08/04 WATERS CORP /DE/ : Management's Discussion and Analysis of Financial Condition a..
08/03 WATERS CORPORATION NYSE : WAT Reports Second Quarter 2017 Financial Results
08/03 WATERS : Findings on Mass Spectrometry Discussed by Investigators at Waters Corp..
08/02 EARNINGS REVIEW AND FREE RESEARCH RE : Waters Corp.’s Quarterly Sales Grew..
08/02 WATERS CORPORATION : Earnings Review and Free Research Report: Waters Corp.’s Qu..
More news
News from SeekingAlpha
10/17 Softer outlook from Sartorius pressures lab products makers
10/11 Seeking Alpha? Here's Alpha
09/12 Waters Corporation's (WAT) CEO Chris O'Connell Presents at 2017 Morgan Stanle..
08/28 Tracking Al Gore's Generation Investment Management Portfolio - Q2 2017 Updat..
08/23 Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2017 Update
Financials ($)
Sales 2017 2 275 M
EBIT 2017 697 M
Net income 2017 571 M
Finance 2017 1 353 M
Yield 2017 -
P/E ratio 2017 25,61
P/E ratio 2018 23,29
EV / Sales 2017 5,75x
EV / Sales 2018 5,35x
Capitalization 14 442 M
Duration : Period :
Waters Corporation Technical Analysis Chart | WAT | US9418481035 | 4-Traders
Technical analysis trends WATERS CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 191 $
Spread / Average Target 5,6%
EPS Revisions
Christopher James O'Connell President, Chief Executive Officer & Director
Douglas A. Berthiaume Chairman
David A. Terricciano Senior Vice President-Global Operations
Sherry L. Buck Chief Financial Officer & Senior Vice President
Edward W. Conard Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER11.56%59 229
ROYAL PHILIPS19.34%38 039